Ex-Blue Origin President-Led SPAC C5 Acquisition Prices US$250 Million IPO

Blank check company C5 Acquisition Corporation (NYSE: CXAC.U) is looking to raise US$250 million for its initial public offering. The company went public on Friday on the New York Stock Exchange and is expected to close on January 11, 2022.

The offering consists of 25.0 million company units selling at US$10.00 per unit. Each unit consists of one Class A share and one-half of a purchase warrant. Each whole warrant is exercisable to purchase one whole Class A share at US$11.50 per share. The shares and the warrants will be trading on the New York-based big board under symbols “CXAC” and “CXAC.WS”, respectively.

The underwriters were granted a 45-day option to purchase an additional 3.75 million units at the same IPO price. Cantor Fitzgerald & Co. and Moelis & Company act as joint bookrunners for the proposed offering.

Antimony Resources — sponsored Sponsored · Antimony Resources

The SPAC is led by former Blue Origin president Robert Meyerson as CEO and Jacobs Engineering CEO Steve Demetriou as the non-executive chairman of the board. The blank check firm is planning to focus its search for business combinations in three key sectors: space, cybersecurity, and energy transition.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Trending

Related News

Oncology Firm Erasca Eyes US$300 Million IPO

Precision oncology company Erasca Inc. (NASDAQ: ERAS) began trading on the Nasdaq Global Select Market...

Friday, July 16, 2021, 11:20:00 AM

HempFusion Files For US$17 Million Initial Public Offering

HempFusion Wellness, the CBD firm that caused much excitement last year when it conducted a...

Thursday, October 22, 2020, 10:32:49 AM

Biotech SPAC BioPlus Acquisition Prices US$200 Million IPO

Special purpose acquisition company BioPlus Acquisition Corp. (Nasdaq: BIOSU) started trading publicly on the Nasdaq...

Monday, December 6, 2021, 02:19:00 PM

New York-Based Bank Hanover Bancorp Prices US$26.8 Million IPO

New-York headquartered bank conglomerate Hanover Bancorp, Inc. (Nasdaq: HNVR) began trading on the Nasdaq Global...

Thursday, May 12, 2022, 02:24:00 PM

Tech SPAC AxonPrime Infrastructure Acquisition Conducts US$150 Million IPO

Special purpose acquisition company AxonPrime Infrastructure Acquisition Corporation (Nasdaq: APMIU) started trading publicly on the...

Monday, August 16, 2021, 10:49:00 AM